Details for Patent: 7,053,092

Which drugs does patent 7,053,092 protect, and when does it expire?

Patent 7,053,092 protects ABILIFY and ABILIFY MYCITE KIT and is included in four NDAs.

Summary for Patent: 7,053,092

Title:	5-HT1a receptor subtype agonist
Abstract:	The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT.sub.1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1): ##STR00001## wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.
Inventor(s):	Jordon; Shaun (Germantown, MD), Kikuchi; Tetsuro (Tokushima, JP), Tottori; Katsura (Kamiita-cho, JP), Hirose; Tsuyoshi (Tokushima, JP), Uwahodo; Yasufumi (Tokushima, JP)
Assignee:	Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:	10/055,915
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,053,092
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 7,053,092

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Otsuka	ABILIFY	aripiprazole	SOLUTION;ORAL	021713-001	Dec 10, 2004		DISCN	Yes	No						TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka	ABILIFY	aripiprazole	TABLET, ORALLY DISINTEGRATING;ORAL	021729-002	Jun 7, 2006		DISCN	Yes	No						TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka	ABILIFY	aripiprazole	TABLET, ORALLY DISINTEGRATING;ORAL	021729-003	Jun 7, 2006		DISCN	Yes	No						TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka	ABILIFY	aripiprazole	TABLET, ORALLY DISINTEGRATING;ORAL	021729-004	Jun 7, 2006		DISCN	Yes	No						TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka	ABILIFY	aripiprazole	TABLET, ORALLY DISINTEGRATING;ORAL	021729-005	Jun 7, 2006		DISCN	Yes	No						TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka	ABILIFY	aripiprazole	TABLET;ORAL	021436-006	Nov 15, 2002	AB	RX	Yes	No						TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)